Cargando…

Prevalence of age-related macular degeneration in Iran and its projections through 2050: a systematic review and meta-analysis

BACKGROUND: Age-related Macular Degeneration (AMD) is one of the most common causes of vision loss. A substantial increase in the burden of AMD is expected in the aging populations, including the Iranians. We investigated the age and gender-specific prevalence of AMD and its determinants in Iran. ME...

Descripción completa

Detalles Bibliográficos
Autores principales: Roshanshad, Amirhossein, Roshanshad, Romina, Moosavi, Seyed Ali, Ardekani, Ali, Nabavizadeh, Sara Sadat, Fereidooni, Reza, Ashraf, Hossein, Vardanjani, Hossein Molavi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10675929/
https://www.ncbi.nlm.nih.gov/pubmed/38007475
http://dx.doi.org/10.1186/s12886-023-03218-3
_version_ 1785149878559571968
author Roshanshad, Amirhossein
Roshanshad, Romina
Moosavi, Seyed Ali
Ardekani, Ali
Nabavizadeh, Sara Sadat
Fereidooni, Reza
Ashraf, Hossein
Vardanjani, Hossein Molavi
author_facet Roshanshad, Amirhossein
Roshanshad, Romina
Moosavi, Seyed Ali
Ardekani, Ali
Nabavizadeh, Sara Sadat
Fereidooni, Reza
Ashraf, Hossein
Vardanjani, Hossein Molavi
author_sort Roshanshad, Amirhossein
collection PubMed
description BACKGROUND: Age-related Macular Degeneration (AMD) is one of the most common causes of vision loss. A substantial increase in the burden of AMD is expected in the aging populations, including the Iranians. We investigated the age and gender-specific prevalence of AMD and its determinants in Iran. METHODS: We systematically searched international (PubMed, Scopus, Embase, etc.) and local (IranDoc, Magiran, etc.) online databases. We included cross-sectional or cohort studies, either clinic- or population-based, published on the prevalence of AMD among Iranians, with no limitation on age. Joanna Briggs Institute (JBI) tools for critical appraisal were used. Prevalence estimates are pooled by applying random-effects modeling. Subgroup analysis and meta-regression were performed. RESULTS: Seventeen studies with 16,120 participants were included. Based on studies in general population, the pooled prevalence of AMD was 10.8% (95% CI: 6.5-16.2%) in males, and 9.8% (95% CI: 4.7-16.4%) in females. 8.5% of moderate vision impaired, 13.6% of severe vision impaired, and 15.7% of blind participants were affected by AMD. The prevalence of AMD was 2% in 40–49, and 32.3% in the ≥ 80 population. The prevalence of AMD was 11.9% among the visually impaired vs. 8.7% in the general population. The study’s sampling method, location, and mean age were correlated with the heterogeneities of the prevalence. We observed an increasing trend in the number of AMD cases (average annual percent change = 3.66%; 95% CI: 3.65–3.67%) from 1990 to 2050. The expected number of AMD cases in Iran will be near 5.5 million by 2050. CONCLUSION: The prevalence of AMD in Iran was somewhere between the prevalence of Asians and Europeans. Given the aging trend of the Iranian community and an average annual percent change of 3.66%, it is indispensable to adopt preventive and screening policies to diminish the burden of the disease in the future decades. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12886-023-03218-3.
format Online
Article
Text
id pubmed-10675929
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-106759292023-11-25 Prevalence of age-related macular degeneration in Iran and its projections through 2050: a systematic review and meta-analysis Roshanshad, Amirhossein Roshanshad, Romina Moosavi, Seyed Ali Ardekani, Ali Nabavizadeh, Sara Sadat Fereidooni, Reza Ashraf, Hossein Vardanjani, Hossein Molavi BMC Ophthalmol Research BACKGROUND: Age-related Macular Degeneration (AMD) is one of the most common causes of vision loss. A substantial increase in the burden of AMD is expected in the aging populations, including the Iranians. We investigated the age and gender-specific prevalence of AMD and its determinants in Iran. METHODS: We systematically searched international (PubMed, Scopus, Embase, etc.) and local (IranDoc, Magiran, etc.) online databases. We included cross-sectional or cohort studies, either clinic- or population-based, published on the prevalence of AMD among Iranians, with no limitation on age. Joanna Briggs Institute (JBI) tools for critical appraisal were used. Prevalence estimates are pooled by applying random-effects modeling. Subgroup analysis and meta-regression were performed. RESULTS: Seventeen studies with 16,120 participants were included. Based on studies in general population, the pooled prevalence of AMD was 10.8% (95% CI: 6.5-16.2%) in males, and 9.8% (95% CI: 4.7-16.4%) in females. 8.5% of moderate vision impaired, 13.6% of severe vision impaired, and 15.7% of blind participants were affected by AMD. The prevalence of AMD was 2% in 40–49, and 32.3% in the ≥ 80 population. The prevalence of AMD was 11.9% among the visually impaired vs. 8.7% in the general population. The study’s sampling method, location, and mean age were correlated with the heterogeneities of the prevalence. We observed an increasing trend in the number of AMD cases (average annual percent change = 3.66%; 95% CI: 3.65–3.67%) from 1990 to 2050. The expected number of AMD cases in Iran will be near 5.5 million by 2050. CONCLUSION: The prevalence of AMD in Iran was somewhere between the prevalence of Asians and Europeans. Given the aging trend of the Iranian community and an average annual percent change of 3.66%, it is indispensable to adopt preventive and screening policies to diminish the burden of the disease in the future decades. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12886-023-03218-3. BioMed Central 2023-11-25 /pmc/articles/PMC10675929/ /pubmed/38007475 http://dx.doi.org/10.1186/s12886-023-03218-3 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Roshanshad, Amirhossein
Roshanshad, Romina
Moosavi, Seyed Ali
Ardekani, Ali
Nabavizadeh, Sara Sadat
Fereidooni, Reza
Ashraf, Hossein
Vardanjani, Hossein Molavi
Prevalence of age-related macular degeneration in Iran and its projections through 2050: a systematic review and meta-analysis
title Prevalence of age-related macular degeneration in Iran and its projections through 2050: a systematic review and meta-analysis
title_full Prevalence of age-related macular degeneration in Iran and its projections through 2050: a systematic review and meta-analysis
title_fullStr Prevalence of age-related macular degeneration in Iran and its projections through 2050: a systematic review and meta-analysis
title_full_unstemmed Prevalence of age-related macular degeneration in Iran and its projections through 2050: a systematic review and meta-analysis
title_short Prevalence of age-related macular degeneration in Iran and its projections through 2050: a systematic review and meta-analysis
title_sort prevalence of age-related macular degeneration in iran and its projections through 2050: a systematic review and meta-analysis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10675929/
https://www.ncbi.nlm.nih.gov/pubmed/38007475
http://dx.doi.org/10.1186/s12886-023-03218-3
work_keys_str_mv AT roshanshadamirhossein prevalenceofagerelatedmaculardegenerationinirananditsprojectionsthrough2050asystematicreviewandmetaanalysis
AT roshanshadromina prevalenceofagerelatedmaculardegenerationinirananditsprojectionsthrough2050asystematicreviewandmetaanalysis
AT moosaviseyedali prevalenceofagerelatedmaculardegenerationinirananditsprojectionsthrough2050asystematicreviewandmetaanalysis
AT ardekaniali prevalenceofagerelatedmaculardegenerationinirananditsprojectionsthrough2050asystematicreviewandmetaanalysis
AT nabavizadehsarasadat prevalenceofagerelatedmaculardegenerationinirananditsprojectionsthrough2050asystematicreviewandmetaanalysis
AT fereidoonireza prevalenceofagerelatedmaculardegenerationinirananditsprojectionsthrough2050asystematicreviewandmetaanalysis
AT ashrafhossein prevalenceofagerelatedmaculardegenerationinirananditsprojectionsthrough2050asystematicreviewandmetaanalysis
AT vardanjanihosseinmolavi prevalenceofagerelatedmaculardegenerationinirananditsprojectionsthrough2050asystematicreviewandmetaanalysis